Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 16/20 | 0.57 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.55 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4066048 | 0.91 | KCNH2 (0.57) | KCNH2KCNQ1CACNA1C | |
| SCHEMBL2954037 | 0.89 | KCNH2 (0.57) | KCNH2KCNQ1CACNA1C | |
| SCHEMBL2952672 | 0.88 | KCNH2 (0.50) | KCNH2KCNQ1CACNA1C | |
| SCHEMBL4071573 | 0.87 | KCNH2 (0.63) | KCNH2KCNQ1CACNA1C | |
| SCHEMBL2954872 | 0.86 | KCNH2 (0.65) | KCNH2 | |
| SCHEMBL2946555 | 0.86 | KCNH2 (0.48) | KCNH2KCNQ1CACNA1C | |
| SCHEMBL4067925 | 0.82 | KCNH2 (0.49) | KCNH2KCNQ1CACNA1C | |
| SCHEMBL4065915 | 0.80 | KCNH2 (0.52) | KCNH2KCNQ1CACNA1C | |
| SCHEMBL4074247 | 0.80 | KCNH2 (0.57) | KCNH2KCNQ1CACNA1C | |
| SCHEMBL4067923 | 0.79 | KCNH2 (0.57) | KCNH2KCNQ1CACNA1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7759340-B2 | Antibacterial agents | GLAXO GROUP LIMITED (GB) | 2010-07-20 | — | — | US | disclosed |
| US-7758849-B2 | Hair wax products containing silicone wax, silicone-free wax and oils | WELLA AG (DE) | 2010-07-20 | — | — | US | disclosed |
| US-7759340-B2 | Antibacterial agents | GLAXO GROUP LIMITED (GB) | 2010-07-20 | — | — | US | disclosed |
| US-7759340-B2 | Antibacterial agents | GLAXO GROUP LIMITED (GB) | 2010-07-20 | — | — | US | disclosed |
| US-20090181955-A1 | Antibacterial Agents | MILLER WILLIAM HENRY | 2009-07-16 | — | — | US | disclosed |
| US-20090181955-A1 | Antibacterial Agents | MILLER WILLIAM HENRY | 2009-07-16 | — | — | US | disclosed |
| US-20090181955-A1 | Antibacterial Agents | MILLER WILLIAM HENRY | 2009-07-16 | — | — | US | disclosed |
| US-7511035-B2 | Antibacterial agents | GLAXO GROUP LIMITED (GB) | 2009-03-31 | — | — | US | disclosed |
| US-7511035-B2 | Antibacterial agents | GLAXO GROUP LIMITED (GB) | 2009-03-31 | — | — | US | disclosed |
| US-7511035-B2 | Antibacterial agents | GLAXO GROUP LIMITED (GB) | 2009-03-31 | — | — | US | disclosed |
| US-20030118538-A1 | Sprayable hair gels | WELLA AKTIENGESELLSCHAFT (DE) | 2003-06-26 | — | — | US | disclosed |
| US-20030049224-A1 | Hair treatment gels containing itaconic acid monoester/acrylate copolymer | Wella GmbH (DE) | 2003-03-13 | — | — | US | disclosed |
| US-6475475-B2 | A BLEND OF AT LEAST ONE TERPOLYMER OF VINYL PYRROLIDONE, VINYL CAPROLACTAM AND A BASIC ACRYLAMIDE MONOMER, AND AT LEAST ONE POLYMER HAVING ANIONIC OR ANIONIZABLE GROUPS; HAIR FIXING; MORE ELASTIC FILM; SOFTNESS | WELLA AKTIENGESELLSCHAFT (DE) | 2002-11-05 | — | — | US | disclosed |
| US-20020076387-A1 | Solid, form-stable gels for hair treatment | WELLA AKTIENGESELLSCHAFT (DE) | 2002-06-20 | — | — | US | disclosed |
| US-6372203-B1 | Hair treatment compositions with polymers made from unsaturated saccharides, unsaturated saccharic acids or their derivatives | WELLA AKTIENGESELLSCHAFT (DE) | 2002-04-16 | — | — | US | disclosed |
| US-6368581-B1 | MIXTURE OF POLYOXYALKYLENE GLYCOL GLYCERIDE AND SURFACTANT | WELLA AKTIENGESELLSCHAFT (DE) | 2002-04-09 | — | — | US | disclosed |
| US-6358493-B1 | Methods of performing cosmetic treatments with gasified solid particles and instant gel preparations containing the gasified solid particles | WELLA AKTIENGESELLSCHAFT (DE) | 2002-03-19 | — | — | US | disclosed |
| US-6328950-B1 | FOR TEMPORARILY COLORING HAIR | WELLA AKTIENGESELLSCHAFT (DE) | 2001-12-11 | — | — | US | disclosed |
| US-20010026791-A1 | Gel composition and thickened hair treatment composition | Wella Aktiengessellschaft (DE) | 2001-10-04 | — | — | US | disclosed |
| US-6264929-B1 | COMPLEX | WELLA AKTIENGESELLSCHAFT (DE) | 2001-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090181955-A1 | Antibacterial Agents | NQO2, NQO1, NRDC | KCNH2 3002/4885KCNQ1 1726/4885CACNA1C 4458/4885 |
| US-20020076387-A1 | Solid, form-stable gels for hair treatment | KCNN1, KCNN2, KCNN3 | KCNH2 18/4885KCNQ1 213/4885CACNA1C 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.